Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2009-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011511792-A |
titleOfInvention |
Prodrug of CGRP receptor antagonist |
abstract |
A compound of formula (I) that is an analog of an antagonist of the CGRP receptor and is useful for the treatment or prevention of diseases involving CGRP, such as migraine Disclosed are prodrug compounds wherein the variables R 1 and R 2 are described herein. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7014811-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7295944-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020508325-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022512687-A |
priorityDate |
2008-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |